💎 Fed’s first rate cut since 2020 set to trigger market. Find undervalued gems with Fair ValueSee Undervalued Stocks

Monsanto ordered to pay $289 million in world's first Roundup cancer trial

Published 08/10/2018, 09:30 PM
© Reuters. FILE PHOTO: Monsanto Co's Roundup shown for sale in California
BAYGN
-
LCO
-
MON
-

By Tina Bellon

(Reuters) - A California jury on Friday found Monsanto (NYSE:MON) liable in a lawsuit filed by a man who alleged the company's glyphosate-based weed-killers, including Roundup, caused his cancer and ordered the company to pay $289 million in damages.

The case of school groundskeeper Dewayne Johnson was the first lawsuit to go to trial alleging glyphosate causes cancer. Monsanto, a unit of Bayer AG (DE:BAYGN) following a $62.5 billion acquisition by the German conglomerate, faces more than 5,000 similar lawsuits across the United States.

The jury at San Francisco's Superior Court of California deliberated for three days before finding that Monsanto had failed to warn Johnson and other consumers of the cancer risks posed by its weed killers.

It awarded $39 million in compensatory and $250 million in punitive damages.

Monsanto in a statement said it would appeal the verdict. "Today’s decision does not change the fact that more than 800 scientific studies and reviews...support the fact that glyphosate does not cause cancer, and did not cause Mr. Johnson’s cancer," the company said.

Monsanto denies that glyphosate, the world's most widely used herbicide, causes cancer and says decades of scientific studies have shown the chemical to be safe for human use.

Johnson's case, filed in 2016, was fast-tracked for trial due to the severity of his non-Hodgkin's lymphoma, a cancer of the lymph system that he alleges was caused by Roundup and Ranger Pro, another Monsanto glyphosate herbicide. Johnson's doctors said he is unlikely to live past 2020.

A former pest control manager for a California county school system, Johnson, 46, applied the weed killer up to 30 times per year.

Brent Wisner, a lawyer for Johnson, in a statement said jurors for the first time had seen internal company documents "proving that Monsanto has known for decades that glyphosate and specifically Roundup could cause cancer." He called on Monsanto to "put consumer safety first over profits."

Over the course of the four-week trial, jurors heard testimony by statisticians, doctors, public health researchers and epidemiologists who disagreed on whether glyphosate can cause cancer.

© Reuters. FILE PHOTO: Monsanto Co's Roundup shown for sale in California

The U.S. Environmental Protection Agency in September 2017 concluded a decades-long assessment of glyphosate risks and found the chemical not likely carcinogenic to humans. But the World Health Organization's cancer arm in 2015 classified glyphosate as "probably carcinogenic to humans."

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.